Company intelligence / Profile preview
Recordati SpA
Milan, Italyrecordati.com ↗
- Ownership
- Public · RECI
- Employees
- ~4580
- Development stage
- Other
01
Overview
Recordati has over 190 marketed drugs across multiple therapeutic areas, with a focus on both common diseases and rare conditions. They have products in various stages of development from preclinical to post-marketing.
- Therapeutic areas
- CardiovascularPsychiatryMetabolic DisordersOphthalmologyEndocrinologyOncologyRare Diseases
- Modalities
- Small moleculespharmaceuticals
- Industry
- Biotech
02
Drug pipeline
27 assets26 more assets in the full pipeline.
03
Partnerships
Beyond the preview
Go deeper on Recordati SpA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Recordati SpA.